This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2013; 99(1): 63.23095139Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss20139916310.1016/j.fertnstert.2012.09.02323095139Search in Google Scholar
Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010; 93(4): 1234-1243.10.1016/j.fertnstert.2009.01.16619338986JaslowCRCarneyJLKuttehWHDiagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses20109341234124319338986Open DOISearch in Google Scholar
Ford HB, Schust DJ. Recurrent pregnancy loss: Etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009; 2(2): 76-83.19609401FordHBSchustDJRecurrent pregnancy loss: Etiology, diagnosis, and therapy2009227683Search in Google Scholar
Jeve YB, Davies W. Evidence-based management of recurrent miscarriages. J Hum Reprod Sci. 2014; 7(3): 159-169.10.4103/0974-1208.14247525395740JeveYBDaviesWEvidence-based management of recurrent miscarriages201473159169422979025395740Open DOISearch in Google Scholar
Christiansen OB. Reproductive immunology. Mol Immunol. 2013; 55(1): 8-15.10.1016/j.molimm.2012.08.02523062611ChristiansenOBReproductive immunology201355181523062611Open DOISearch in Google Scholar
Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard AR, Govande V, et al. Inflammation in complicated pregnancy and its outcome. Am J Perinatal. 2016; 33(14): 1337-1356.10.1055/s-0036-1582397KalagiriRRCarderTChoudhurySVoraNBallardARGovandeVet alInflammation in complicated pregnancy and its outcome201633141337135627159203Open DOISearch in Google Scholar
Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: The role of the immune system at the implantation site. Ann NY Acad Sci. 2011; 1221(1): 80-87.10.1111/j.1749-6632.2010.05938.xMorGCardenasIAbrahamsVGullerSInflammation and pregnancy: The role of the immune system at the implantation site2011122118087307858621401634Open DOISearch in Google Scholar
Doni A, Garlanda C, Mantovani A. Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Semin Immunol. 2016; 28(6): 570-577.10.1016/j.smim.2016.10.01227881292DoniAGarlandaCMantovaniAInnate immunity, hemostasis and matrix remodeling: PTX3 as a link2016286570577541483327881292Open DOISearch in Google Scholar
Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010; 28: 157-183.1996856110.1146/annurev-immunol-030409-101305BottazziBDoniAGarlandaCMantovaniAAn integrated view of humoral innate immunity: pentraxins as a paradigm20102815718319968561Search in Google Scholar
Garlanda C, Maina V, Cotena A, Moalli F. The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility. J Reprod Immunol. 2009; 83(1-2): 128-133.10.1016/j.jri.2009.05.00619900712GarlandaCMainaVCotenaAMoalliFThe soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility2009831-212813319900712Open DOISearch in Google Scholar
Casula M, Montecucco F, Bonaventura A, Liberale L, Vecchié A, Dallegri F, et al. Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases. Vascul Pharmacol. 2017; 99: 1-12.2905108810.1016/j.vph.2017.10.003CasulaMMontecuccoFBonaventuraALiberaleLVecchiéADallegriFet alUpdate on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases20179911229051088Search in Google Scholar
Larsson A, Palm M, Helmersson J, Axelsson O. Pentraxin 3 values during normal pregnancy. Inflammation. 2011; 34(5): 448-451.10.1007/s10753-010-9252-x20852923LarssonAPalmMHelmerssonJAxelssonOPentraxin 3 values during normal pregnancy201134544845120852923Open DOISearch in Google Scholar
Lekva T, Michelsen AE, Bollerslev J, Norwitz ER, Aukrust P, Henriksen T, et al. Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: A 5-year follow-up study. Cardiovasc Diabetol. 2016; 15:23.10.1186/s12933-016-0345-126842615LekvaTMichelsenAEBollerslevJNorwitzERAukrustPHenriksenTet alLow circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: A 5-year follow-up study20161523473942626842615Open DOISearch in Google Scholar
Rovere-Querini P, Antonacci S, Dell'Antonio G, Angeli A, Almirante G, Cin ED. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006; 108(1): 148-155.10.1097/01.AOG.0000224607.46622.bcRovere-QueriniPAntonacciSDell'AntonioGAngeliAAlmiranteGCinEDPlasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia2006108114815516816069Open DOISearch in Google Scholar
Willeke F, Assad A, Findeisen P, Schromm E, Grobholz R, von Gerstenbergk B, et al. Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma. Eur J Cancer. 2006; 42(15): 2639-2646.1695948510.1016/j.ejca.2006.05.035WillekeFAssadAFindeisenPSchrommEGrobholzRvonGerstenbergk Bet alOverexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma200642152639264616959485Search in Google Scholar
Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, et al. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol. 2014; 165(3): 165-178.10.1159/000368778JaillonSBonavitaEGentileSRubinoMLafaceIGarlandaCet alThe long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases2014165316517825531094Open DOISearch in Google Scholar
Giacomini A, Ghedini GC, Presta M, Ronca, R. Long pentraxin 3: A novel multifaceted player in cancer. Biochim Biophys Acta. 2018; 1869(1): 53-63.GiacominiAGhediniGCPrestaMRoncaRLong pentraxin 3: A novel multifaceted player in cancer201818691536310.1016/j.bbcan.2017.11.00429175552Search in Google Scholar
Cozzi V, Garlanda C, Nebuloni M, Maina V, Martinelli A, Calabrese S, et al. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta. 2012; 33(12): 1039-1044.10.1016/j.placenta.2012.09.00923062219CozziVGarlandaCNebuloniMMainaVMartinelliACalabreseSet alPTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR201233121039104423062219Open DOISearch in Google Scholar
Zhou P, Luo X, Qi HB,Zong WJ, Zhang H, Liu DD, et al. The expression of pentraxin 3 and tumor necrosis factor-α is increased in preeclamptic placentai tissue and maternal serum. Inflamm Res. 2012; 61(9): 10051012.ZhouPLuoXQiHBZongWJZhangHLiuDDet alThe expression of pentraxin 3 and tumor necrosis factor-α is increased in preeclamptic placentai tissue and maternal serum20126191005101210.1007/s00011-012-0507-x22714118Search in Google Scholar
Akolekar R, Casagrandi D, Livanos P, Tetteh A, Nicolaides KH. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009; 29(10): 934-938.1956560910.1002/pd.2311AkolekarRCasagrandiDLivanosPTettehANicolaidesKHMaternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy2009291093493819565609Search in Google Scholar
Baschat AA, Kasdaglis TL, Aberdeen GW, Turan OM, Kopelman JL, Atlas R, et al. Serum pentraxin-3 levels at 11 to 14 weeks' gestation: Association with maternal and placentai characteristics. Am J Obstet Gynecol. 2009; 201(3): 298.el-298.e6.19631929BaschatAAKasdaglisTLAberdeenGWTuranOMKopelmanJLAtlasRet alSerum pentraxin-3 levels at 11 to 14 weeks' gestation: Association with maternal and placentai characteristics20092013298el-298.e610.1016/j.ajog.2009.05.03919631929Search in Google Scholar
Cetin I, Cozzi V, Papageorghiou AT, Maina V, Montanelli A, Garlanda C, et al. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction. Acta Obstet Gynecol Scand. 2009; 88(7): 846-849.1954420210.1080/00016340902971441CetinICozziVPapageorghiouATMainaVMontanelliAGarlandaCet alFirst trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction200988784684919544202Search in Google Scholar
Tranguch S, Chakrabarty A, Guo Y, Wang H, Dey SK. Maternal pentraxin 3 deficiency compromises implantation in mice. Biol Reprod. 2007; 77(3): 425-432.10.1095/biolreprod.107.06241417538075TranguchSChakrabartyAGuoYWangHDeySKMaternal pentraxin 3 deficiency compromises implantation in mice200777342543217538075Open DOISearch in Google Scholar
Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, et al. Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology. 2006; 147(12): 5662-5675.10.1210/en.2006-0916PopoviciRMBetzlerNKKrauseMSLuoMJauckusJGermeyerAet alGene expression profiling of human endometrial-trophoblast interaction in a coculture model2006147125662567516946011Open DOISearch in Google Scholar
Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, et al. Decidual stromal cell response to paracrine signals from the trophoblast: Amplification of immune and angiogenic modulators. Biol Reprod. 2007; 76(1): 102-117.10.1095/biolreprod.106.05479117021345HessAPHamiltonAETalbiSDosiouCNyegaardMNayakNet alDecidual stromal cell response to paracrine signals from the trophoblast: Amplification of immune and angiogenic modulators200776110211717021345Open DOISearch in Google Scholar
Cruciani L, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Mazaki-Tovi S, et al. Pentraxin 3 in maternal circulation: An association with preterm labor and preterm PROM, but not with intra-amniotic infection/innammation. J Matern Fetal Neonatal Med. 2010; 23(10): 1097-1105.10.3109/14767050903551509CrucianiLRomeroRVaisbuchEKusanovicJPChaiworapongsaTMazaki-ToviSet alPentraxin 3 in maternal circulation: An association with preterm labor and preterm PROM, but not with intra-amniotic infection/innammation2010231010971105347114320121391Open DOISearch in Google Scholar
Assi F, Fruscio R, Bonardi C, Ghidini A, Allavena P, Mantovani A, et al. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. Br J Obstet Gynaecol. 2007; 114(2): 143-147.10.1111/j.1471-0528.2006.01225.xAssiFFruscioRBonardiCGhidiniAAllavenaPMantovaniAet alPentraxin 3 in plasma and vaginal fluid in women with preterm delivery2007114214314717305891Open DOISearch in Google Scholar
Jo YS, Cheon JY, Ahn JW, Kim Y, Lee GSR. Pentraxin 3 and lipid profile status in pregnancy. J Obstet Gynaecol. 2017; 37(3): 727-730.2842185310.1080/01443615.2017.1291596JoYSCheonJYAhnJWKimYLeeGSRPentraxin 3 and lipid profile status in pregnancy201737372773028421853Search in Google Scholar
Ibrahim MI, Harb HM, Ellaithy MI, Elkabarity RH, Abdelgwad MH. First trimester assessment of pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2012; 165(1): 37-41.2288949210.1016/j.ejogrb.2012.07.016IbrahimMIHarbHMEllaithyMIElkabarityRHAbdelgwadMHFirst trimester assessment of pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss20121651374122889492Search in Google Scholar
Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, et al. An alternative role of Clq in cell migration and tissue remodeling: Contribution to trophoblast invasion and placentai development. J Immunol. 2010; 185(7): 4420-4429.10.4049/jimmunol.0903215AgostinisCBullaRTripodoCGismondiAStabileHBossiFet alAn alternative role of Clq in cell migration and tissue remodeling: Contribution to trophoblast invasion and placentai development201018574420442920810993Open DOISearch in Google Scholar
Kouser L, Madhukaran SP, Shastri A, Saraon A, Ferluga J, Al-Mozaini M, et al. Emerging and novel functions of complement protein Clq. Front Immunol. 2015; 6: 317.KouserLMadhukaranSPShastriASaraonAFerlugaJAl-MozainiMet alEmerging and novel functions of complement protein Clq2015631710.3389/fimmu.2015.00317448422926175731Search in Google Scholar
Singh J, Ahmed A, Girardi G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension. 2011; 58(4): 716-724.10.1161/HYPERTENSIONAHA.111.17591921859968SinghJAhmedAGirardiGRole of complement component C1q in the onset of preeclampsia in mice201158471672421859968Open DOISearch in Google Scholar